https://www.gosh.nhs.uk/news/ucl-gos-institute-child-health-gold-athena-swan-award/
UCL GOS Institute for Child Health Gold Athena SWAN award
15 Oct 2020, 10:55 a.m.
Great Ormond Street Hospital’s academic partner, the UCL Great Ormond Street Institute for Child Health (GOS ICH), has been awarded GOLD status through Athena SWAN for its work to improve gender equality and diversity.
The Athena SWAN charter recognises and celebrates practices in research institutions, like the GOS ICH, that promote the advancement of women in science. The GOS ICH was praised for its broad inclusive approach and attempts to incorporate all staff into all activity to improve gender equality. The panel also commended the positive, constructive, and supportive approach they had in response to COVID-19, and their focus on mitigating disparities and inequalities.
GOS ICH Director, Professor Rosalind Smyth, said: “I am immensely proud of this exceptional achievement, which reflects the very positive approach to equality, diversity and inclusion within our community and the hard work of all who have implemented this critically important part of our academic strategy. There are still areas where we need to improve and there are other challenges ahead so we will not be complacent.”
Previously, the GOS ICH had Silver status. This was needed for GOSH and the GOS ICH to be awarded an NIHR Biomedical Research Centre status in 2015.
As an NHS Trust, GOSH is not eligible for an Athena SWAN award. However, the Trust is fully committed to ensuring a more diverse and inclusive workforce. GOSH has recently implemented a new Diversity and Inclusion Framework and set up a Women’s Forum to develop more focus in this area.
NIHR launches £13.7m investment into brain tumour research
The National Institute for Health and Care Research (NIHR) has announced a £13.7 million investment that will support ground-breaking research to develop novel brain tumour treatments in the UK.
New consortium aims to help improve care for arthritis patients
A new UK-led research group, including Great Ormond Street Hospital and University College London, aims to improve the lives of children, young people and adults with arthritis by defining for the first time what being in ‘remission’ from arthritis truly
‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-Cell leukaemia
A groundbreaking new treatment using gene-edited immune cells, developed at GOSH and UCL has shown promising results in helping children and adults fight a rare and aggressive cancer
GOSH manufactures new gene therapy for rare condition
A specialist laboratory team based at Great Ormond Street Hospital have manufactured a new gene therapy to treat a baby with the rare genetic condition, Hunter Syndrome.